Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma

Aim: to determine the frequency of PNPLA3 rs738409 C>G gene polymorphism, leading to p.I148M substitution, in patients with non-alcoholic fatty liver disease (NAFLD), and to reveal the association between polymorphism and probable NAFLD outcomes: liver cirrhosis (LC) and hepatocellular carcin...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2023-11-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	<i>pnpla3</i> nafld liver cirrhosis hepatocellular cancer
Online Access:	https://www.gastro-j.ru/jour/article/view/822
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population
by: Chia-Wen Lu, et al.
Published: (2025-01-01)

PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality
by: Kalliopi Azariadis, et al.
Published: (2024-12-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding
by: Lina Jegodzinski, et al.
Published: (2025-08-01)

PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure
by: V. Pitova, et al.
Published: (2025-07-01)

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01)

Stereotactic radiotherapy with Gamma Master System® for palliation of hepatocellular carcinoma in patients with liver cirrhosis
by: Bin Qiu, et al.
Published: (2025-07-01)

Identification of two novel PNPLA1 mutations in Turkish families with autosomal recessive congenital ichthyosis
by: Serap Dökmeci-Emre, et al.
Published: (2017-08-01)

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level
by: Monika Pazgan-Simon, et al.
Published: (2024-10-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation
by: Hao Xiong, et al.
Published: (2025-03-01)

A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population
by: Satoshi Sato, et al.
Published: (2025-03-01)

Exploring Missense Variants in the Human PNPLA3 Protein: An In Silico Analysis
by: Asia Awad AbdelGader, et al.
Published: (2025-06-01)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
by: Yoshihiro Inoue, et al.
Published: (2020-09-01)

Unraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study
by: Silvia Espina, et al.
Published: (2024-11-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

PNPLA3 in largemouth bass (Micropterus salmoides): Molecular cloning, functional characterization, and its role in high glucose-induced lipid synthesis
by: Yan-Bin Yang, et al.
Published: (2025-07-01)

Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
by: Saisai Zhang, et al.
Published: (2025-02-01)

High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease
by: Ivan Budimir Bekan, et al.
Published: (2025-07-01)

The predictive value of PIV, PLR, LMR, NPR, and NLR for the prognosis of transarterial chemoembolization in patients with hepatocellular carcinoma combined with liver cirrhosis
by: Yanan Wei, et al.
Published: (2025-04-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Compensated advanced chronic liver disease in patients with metabolic dysfunction-associated steatotic liver disease: association with cardiometabolic factors
by: V. P. Gomonova, et al.
Published: (2024-11-01)

Low albumin-to-creatinine ratio: a novel predictor of 90-day mortality in hepatocellular carcinoma with liver cirrhosis
by: Kadek Mercu Narapati Pamungkas, et al.
Published: (2024-11-01)

The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series
by: Fabrizio Bronte, et al.
Published: (2025-05-01)

Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
by: Sniedze Laivacuma, et al.
Published: (2025-04-01)

Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
by: Hiroya Iida, et al.
Published: (2020-03-01)

CT and MR Imaging of Hepatocellular Carcinoma and Liver Cirrhosis
by: Masahiro Okada, et al.
Published: (2024-11-01)

Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01)

Potential of magnetic-resonance tomography in differential diagnostics of liver cirrhosis and hepatocellular carcinoma
by: Ye. A. Kulyushina
Published: (2009-10-01)

Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical cases
by: D. V. Sidorov, et al.
Published: (2020-06-01)

A rat model of cirrhosis with well-differentiated hepatocellular carcinoma induced by thioacetamide
by: Zhiping Hu, et al.
Published: (2024-11-01)

Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
by: Laura Burke, et al.
Published: (2025-01-01)

The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease
by: Aftab Ahmed, et al.
Published: (2024-12-01)

<i>CTC-537E7.3</i> as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications
by: Hyung Seok Kim, et al.
Published: (2025-07-01)

Prognostic factors in patients with hepatocellular cancer with progression after liver transplantation
by: I. A. Dzhanyan, et al.
Published: (2024-06-01)

Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis
by: M. V. Chistyakova, et al.
Published: (2019-05-01)

Splenomegaly and thrombocytopenia in patients with liver cirrhosis
by: Đorđević Jelena, et al.
Published: (2010-01-01)

ERADICATION OF HCV INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: FACTOR OF CANCER PREVENTION OR CARCINOGENESIS?
by: N. A. Malinina, et al.
Published: (2019-06-01)